Leta i den här bloggen


söndag 19 maj 2019

Artikkeleita ubikitiini ja mitokondria

Best matches for ubiquitin and mitochondria:

(2016  uutta tietoa  mitokondria   ubikitiiniproteosomi järjestelmästä(UPS))
 
On the linkage between the ubiquitin-proteasome system and the mitochondria. Lehmann G et al. Biochem Biophys Res Commun. (2016)
 Several metabolic pathways critical for cellular homeostasis occur in the mitochondria. Because of the evolution of mitochondria and their physical separation, these pathways have traditionally been thought to be free from regulation by the ubiquitin-proteasome system. This perception has recently been challenged by evidence for the presence of ubiquitin system components in the mitochondria.
 Furthermore, it has been shown that certain mitochondrial proteins are conjugated by ubiquitin, and some of them are degraded by the proteasome. Of particular interest is the finding that some of these proteins are localized to the inner membrane and matrix, which rules out that their targeting is mediated by the cytosolic ubiquitin system.
However, the extent of the involvement of the ubiquitin system in mitochondrial regulation is not known.
The present study addresses this surprising finding, employing several independent approaches. 
  • First, we identified reported ubiquitin conjugates in human and yeast mitochondria and 
  • found that a large fraction of the mitochondrial proteome (62% in human) is ubiquitinated, with most proteins localized to the inner membrane and matrix.
  •  Next, we searched the literature and found that numerous ubiquitin system components localize to the mitochondria and/or contain mitochondrial targeting sequences. 
  •   Finally, we identified reported protein-protein interactions between ubiquitin system components and mitochondrial proteins. 
These unexpected findings suggest that mitochondrial regulation by the ubiquitin system is fundamental and may have broad biomedical implications.
 
2017  ( Mitokondria , ubikitiiniproteosomisysteemi UPS , pestisidit ja PD)

Effects of Commonly Used Pesticides in China on the Mitochondria and Ubiquitin-Proteasome System in Parkinson's Disease. Chen T et al. Int J Mol Sci. (2017)  Abstract
Evidence continues to accumulate that pesticides are the leading candidates of environmental toxins that may contribute to the pathogenesis of Parkinson's disease. The mechanisms, however, remain largely unclear. According to epidemiological studies, we selected nine representative pesticides (paraquat, rotenone, chlorpyrifos, pendimethalin, endosulfan, fenpyroximate, tebufenpyrad, trichlorphon and carbaryl) which are commonly used in China and detected the effects of the pesticides on mitochondria and ubiquitin-proteasome system (UPS) function.
 Our results reveal that all the nine studied pesticides induce morphological changes of mitochondria at low concentrations. Paraquat, rotenone, chlorpyrifos, pendimethalin, endosulfan, fenpyroximate and tebufenpyrad induced mitochondria fragmentation. Furthermore, some of them (paraquat, rotenone, chlorpyrifos, fenpyroximate and tebufenpyrad) caused a significant dose-dependent decrease of intracellular ATP. Interestingly, these pesticides which induce mitochondria dysfunction also inhibit 26S and 20S proteasome activity. However, two out of the nine pesticides, namely trichlorphon and carbaryl, were found not to cause mitochondrial fragmentation or functional damage, nor inhibit the activity of the proteasome, which provides significant guidance for selection of pesticides in China.
 Moreover, our results demonstrate a potential link between inhibition of mitochondria and the UPS, and pesticide-induced Parkinsonism.

 2015  (Mitofagiaa ja mitokondriahomeostaasia säätelee  RBR-E3-ligaasi PRKN ja mitokondriaalinen deunikitinaasi DUB USP30).
 
USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria. Cunningham CN et al. Nat Cell Biol. (2015)   Multiple lines of evidence indicate that mitochondrial dysfunction is central to Parkinson's disease. Here we investigate the mechanism by which parkin, an E3 ubiquitin ligase (PRKN, RBR- ubiquitin ligase) , and USP30, a mitochondrion-localized deubiquitylase (DUB), regulate mitophagy. We find that mitochondrial damage stimulates parkin to assemble Lys 6, Lys 11 and Lys 63 chains on mitochondria, and that USP30 is a ubiquitin-specific deubiquitylase with a strong preference for cleaving Lys 6- and Lys 11-linked multimers. Using mass spectrometry, we show that recombinant USP30 preferentially removes these linkage types from intact ubiquitylated mitochondria and counteracts parkin-mediated ubiquitin chain formation in cells. These results, combined with a series of chimaera and localization studies, afford insights into the mechanism by which a balance of ubiquitylation and deubiquitylation regulates mitochondrial homeostasis, and suggest a general mechanism for organelle autophagy.

News:  

Search results  Items: 1 to 20 of 2094

2.
Nesari A, Mansouri MT, Khodayar MJ, Rezaei M.
Nutr Neurosci. 2019 May 14:1-11. doi: 10.1080/1028415X.2019.1601888. [Epub ahead of print]
3.
Yin Z, Yang L, Wu F, Fan J, Xu J, Jin Y, Yang G.
Oncol Res. 2019 May 9. doi: 10.3727/096504019X15566157027506. [Epub ahead of print]
4.
Soutar MPM, Kempthorne L, Annuario E, Luft C, Wray S, Ketteler R, Ludtmann MHR, Plun-Favreau H.
Autophagy. 2019 May 7:1-10. doi: 10.1080/15548627.2019.1603549. [Epub ahead of print]
Mitochondrial quality control is essential for maintaining a healthy population of mitochondria. Two proteins associated with Parkinson disease, the kinase PINK1 and the E3 ubiquitin ligase PRKN, play a central role in the selective degradation of heavily damaged mitochondria (mitophagy), thus avoiding their toxic accumulation.
Most of the knowledge on PINK1-PRKN mitophagy comes from in vitro experiments involving the treatment of mammalian cells with high concentrations of mitochondrial uncouplers, ... Thus, there is an urgent need for optimizing the current methods to assess PINK1-PRKN mitophagy in vitro. ..These data unite mitochondrial physiology and mitophagy studies and are a first step toward a consensus on optimal experimental conditions for PINK1-PRKN mitophagy and mitochondrial physiology investigations to be carried out in parallel. PD: Parkinson disease; PINK1: PTEN induced kinase 1; WT: wild-type; ΔΨm: mitochondrial membrane potential.
5.
Xie X, Liu PS, Percipalle P.
Front Immunol. 2019 Apr 17;10:836. doi: 10.3389/fimmu.2019.00836. eCollection 2019.
6.
Wang Y, Liu N, Lu B.
CNS Neurosci Ther. 2019 May 2. doi: 10.1111/cns.13140. [Epub ahead of print] Review.
Mitochondria are double-membrane-encircled organelles existing in most eukaryotic cells and playing important roles in energy production, metabolism, Ca2+ buffering, and cell signaling. Mitophagy is the selective degradation of mitochondria by autophagy.
Mitophagy can effectively remove damaged or stressed mitochondria, which is essential for cellular health. Thanks to the implementation of genetics, cell biology, and proteomics approaches, we are beginning to understand the mechanisms of mitophagy, including the roles of ubiquitin-dependent and receptor-dependent signals on damaged mitochondria in triggering mitophagy.
Mitochondrial dysfunction and defective mitophagy have been broadly associated with neurodegenerative diseases.
This review is aimed at summarizing the mechanisms of mitophagy in higher organisms and the roles of mitophagy in the pathogenesis of neurodegenerative diseases.
 Although many studies have been devoted to elucidating the mitophagy process, a deeper understanding of the mechanisms leading to mitophagy defects in neurodegenerative diseases is required for the development of new therapeutic interventions, taking into account the multifactorial nature of diseases and the phenotypic heterogeneity of patients.
7.
Zhang W, Liu F, Che Z, Wu M, Tang Z, Liu J, Yang D.
Sci China Life Sci. 2019 Apr 23. doi: 10.1007/s11427-018-9505-0. [Epub ahead of print]

 (ASB3 function as E3 ubiquitine ligase) Kirjoitan tästä ASB3 proteiinista erikseen
8.
Wang H, Tan S, Dong J, Zhang J, Yao B, Xu X, Hao Y, Yu C, Zhou H, Zhao L, Peng R.
Environ Sci Pollut Res Int. 2019 Apr 22. doi: 10.1007/s11356-019-04873-0. [Epub ahead of print]
PMID:
31012066
9.
Miller S, Muqit MMK.
Neurosci Lett. 2019 Apr 14;705:7-13. doi: 10.1016/j.neulet.2019.04.029. [Epub ahead of print] Review.
PMID:
30995519
10.
Woodall BP, Orogo AM, Najor RH, Cortez MQ, Moreno ER, Wang H, Divakaruni AS, Murphy AN, Gustafsson ÅB.
JCI Insight. 2019 Apr 16;5. pii: 127713. doi: 10.1172/jci.insight.127713.
11.
Thangaraj A, Periyasamy P, Guo ML, Chivero ET, Callen S, Buch S.
Autophagy. 2019 Apr 16:1-24. doi: 10.1080/15548627.2019.1607686. [Epub ahead of print]
PMID:
30990365
12.
Chao CN, Lai CH, Badrealam KF, Lo JF, Shen CY, Chen CH, Chen RJ, Viswanadha VP, Kuo WW, Huang CY.
J Cell Physiol. 2019 Apr 13. doi: 10.1002/jcp.28614. [Epub ahead of print]
PMID:
30980393
13.
Xu Y, Shen J, Ran Z.
Autophagy. 2019 Apr 5:1-15. doi: 10.1080/15548627.2019.1603547. [Epub ahead of print]
PMID:
30951392
14.
Akiyama H, Umezawa Y, Ishida S, Okada K, Nogami A, Miura O.
Cancer Lett. 2019 Jul 1;453:84-94. doi: 10.1016/j.canlet.2019.03.046. Epub 2019 Apr 1.
PMID:
30946869
15.
Silva KAS, Ghiarone T, Schreiber K, Grant D, White T, Frisard MI, Sukhanov S, Chandrasekar B, Delafontaine P, Yoshida T.
J Appl Physiol (1985). 2019 Apr 4. doi: 10.1152/japplphysiol.00898.2018. [Epub ahead of print]
PMID:
30946636
16.
Wauters F, Cornelissen T, Imberechts D, Martin S, Koentjoro B, Sue C, Vangheluwe P, Vandenberghe W.
Autophagy. 2019 Apr 4:1-20. doi: 10.1080/15548627.2019.1603548. [Epub ahead of print]
PMID:
30945962
17.
Joazeiro CAP.
Nat Rev Mol Cell Biol. 2019 Apr 2. doi: 10.1038/s41580-019-0118-2. [Epub ahead of print] Review.
PMID:
30940912
18.
Lama S, Broda M, Abbas Z, Vaneechoutte D, Belt K, Säll T, Vandepoele K, Van Aken O.
Mol Biol Evol. 2019 May 1;36(5):974-989. doi: 10.1093/molbev/msz031.
19.
Fang EF.
Autophagy. 2019 Jun;15(6):1112-1114. doi: 10.1080/15548627.2019.1596497. Epub 2019 Mar 28.Abstract
Our latest publication on the inhibition of Alzheimer disease (AD) through mitophagy consolidates the 'defective mitophagy hypothesis of AD etiology'. Dementia (majorly AD) affects over 50 million people worldwide, and for AD there is no cure. AD leads to progressive loss of cognition, and pathological hallmarks of AD include aggregates of amyloid-β peptides extracellularly and MAPT (microtubule associated protein tau) intracellularly. However, there is no conclusive link between these pathological markers and cognitive symptoms. Anti-AD drug candidates have repeatedly failed, which led us to investigate other molecular etiologies to guide drug development. Mitochondria produce the majority of cellular ATP, affect Ca2+ and redox signaling, and promote developmental and synaptic plasticity. Mitochondrial dysfunction and accumulation of damaged mitochondria are common in brain tissues from AD patients and transgenic AD animal models, but the underlying molecular mechanisms are not fully understood. Damaged mitochondria are removed through multiple pathways, the major 2 being mitophagy and the ubiquitin proteasome pathway. Mitophagy is essential for clearance of damaged mitochondria to maintain mitochondrial homeostasis, ATP production, and neuronal activity and survival. These pieces of evidence converge on the 'defective mitophagy hypothesis of AD etiology', and the current cross-species study provides strong support for this hypothesis.
20.
Andrés-Benito P, Gelpi E, Povedano M, Ausín K, Fernández-Irigoyen J, Santamaría E, Ferrer I.
J Alzheimers Dis. 2019;68(3):1287-1307. doi: 10.3233/JAD-181123.
PMID:
30909235

Inga kommentarer:

Skicka en kommentar